MNA
ABBV icon

Manning & Napier Advisors’s AbbVie ABBV Stock Holding History

Manning & Napier Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$144K Buy
663
+307
+86% +$68.1K ﹤0.01% 326
2025
Q4 		$81.8K Buy
356
+92
+35% +$21K ﹤0.01% 322
2025
Q3 		$61.1K Buy
+264
New +$53.8K ﹤0.01% 329
2017
Q3 		$22.7M Sell
254,936
-3,120
-1% -$238K 0.19% 82
2017
Q2 		$18.7M Buy
258,056
+89,903
+53% +$6.04M 0.16% 87
2017
Q1 		$11M Buy
168,153
+7,427
+5% +$467K 0.08% 104
2016
Q4 		$10.1M Buy
160,726
+3,183
+2% +$194K 0.07% 119
2016
Q3 		$9.94M Sell
157,543
-1,715
-1% -$111K 0.06% 122
2016
Q2 		$9.86M Buy
+159,258
New +$9.7M 0.06% 125
2015
Q2 		– Sell
-187,414
Closed -$11M – 348
2015
Q1 		$11M Sell
187,414
-37
-0% -$2.23K 0.05% 155
2014
Q4 		$12.3M Buy
187,451
+1,363
+0.7% +$85.9K 0.05% 146
2014
Q3 		$10.7M Sell
186,088
-5,941
-3% -$330K 0.04% 160
2014
Q2 		$10.8M Buy
192,029
+45,952
+31% +$2.41M 0.04% 166
2014
Q1 		$7.51M Sell
146,077
-2,988
-2% -$151K 0.03% 201
2013
Q4 		$7.87M Sell
149,065
-78,592
-35% -$3.86M 0.04% 168
2013
Q3 		$10.2M Buy
227,657
+1,463
+0.6% +$64.9K 0.05% 156
2013
Q2 		$9.35M Buy
+226,194
New +$9.89M 0.05% 162

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Manning & Napier Advisors's ABBV Position: Q1 2026 in Review

Manning & Napier Advisors increased its AbbVie (ABBV) stake by 86% in Q1 2026, buying an estimated $68.1K and bringing the position to 663 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #326.

Manning & Napier Advisors first reported a position in ABBV in Q2 2013 and has held it in 17 quarters since. The position peaked at $22.7M in Q3 2017. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Manning & Napier Advisors held 663 shares of AbbVie worth $144K as of Q1 2026.
  • Manning & Napier Advisors bought 307 AbbVie shares in Q1 2026, an estimated $68.1K.
  • AbbVie made up ﹤0.01% of Manning & Napier Advisors's portfolio in Q1 2026, its #326 holding.
  • Manning & Napier Advisors first reported a position in AbbVie in Q2 2013 and has held it in 17 quarters since.
  • Manning & Napier Advisors's AbbVie position peaked at $22.7M in Q3 2017.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Manning & Napier Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.